La cadena de opciones muestra datos clave de las opciones de acciones de Eledon Pharmaceuticals a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Eledon Pharmaceuticals..

Eledon Pharmaceuticals (NASDAQ:ELDN) Bolsa, Cadena de Opciones

Eledon Pharma

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Eledon Pharmaceuticals, Inc. - Common Stock

Eledon Pharmaceuticals Inc

Eledon Pharmaceuticals, Inc. Quarterly Report (Form10) (Amended)

Eledon Pharmaceuticals, Inc. Quarterly Report (Form10)

Eledon Pharmaceuticals GAAP EPS of -$0.13

Buy Rating for Eledon Pharmaceuticals: Promising Kidney Transplant Treatment and Strong Financial Position

Craig-Hallum Remains a Buy on Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Advances in Transplant Trials

News

Press Releases

Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025

ELDN

Achieve Life Sciences, Inc. - Common Shares

Achieve Life Sciences

Actuate Therapeutics, Inc. - Common stock

Actuate Therapeutics

Agenus

Anika Therapeutics

Black Diamond Therapeutics, Inc. - Common Stock

Black Diamond Therapeutic

Cabaletta Bio

Coherus Oncology

Climb Bio

Cardiff Oncology

Citius Oncology

Eledon Pharmaceuticals

Elicio Therapeutics

Forte Biosciences

Greenwich LifeSciences, Inc. - Common stock

Greenwich LifeSciences

Genelux

TuHURA Biosciences

Inhibikase Therapeutics, Inc. - Common Stock

Inhibikase Therapeutics

Kyverna Therapeutics, Inc. - Common Stock

Kyverna Therapeutics

Seres Therapeutics

MEI Pharma

Molecular Partners AG - American Depositary Shares

Molecular Partners

Nkarta

Nuvectis Pharma

Sangamo Therapeutics, Inc. - Common Stock

Sangamo Therapeutics

Theratechnologies

Zura Bio Limited - Class A Ordinary shares

Zura Bio

Craig-Hallum

HC Wainwright & Co.

Noble Capital Markets

Cantor Fitzgerald

Screenshot 2025-03-12 at 4.47.01 PM

Biotech

General

AMGN

BIIB

TNXP

Tonix&#39;s TNX-1500 Shows Promise In Preventing Organ Transplant Rejections Of Either Human Or Pig Organs; Autoimmune Diseases Also A Target

Comments

Eledon Pharmaceuticals

Eledon Pharmaceuticals (ELDN) Opciones

Eledon Pharmaceuticals (NASDAQ:ELDN) Bolsa, Cadena de Opciones

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL